Associated Banc Corp Has $1.04 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Associated Banc Corp decreased its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,597 shares of the exchange traded fund’s stock after selling 593 shares during the period. Associated Banc Corp’s holdings in SPDR S&P Biotech ETF were worth $1,044,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also added to or reduced their stakes in the business. Healthcare of Ontario Pension Plan Trust Fund grew its stake in SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd acquired a new stake in SPDR S&P Biotech ETF during the third quarter worth approximately $141,284,000. Proficio Capital Partners LLC boosted its holdings in SPDR S&P Biotech ETF by 16,156.1% in the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after acquiring an additional 911,686 shares in the last quarter. Mirae Asset Securities USA Inc. grew its stake in SPDR S&P Biotech ETF by 50.0% in the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after acquiring an additional 300,000 shares during the period. Finally, Raymond James Financial Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth approximately $55,529,000.

SPDR S&P Biotech ETF Stock Up 1.3 %

Shares of NYSEARCA:XBI opened at $87.13 on Friday. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The stock’s 50 day moving average is $90.06 and its 200-day moving average is $94.82. The firm has a market capitalization of $5.65 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.